Egyptian International Pharmaceutical Investments (CAI:PHAR) Interest Expense : E£-1,124 Mil (TTM As of Mar. 2025)

View and export this data going back to 1995. Start your Free Trial

What is Egyptian International Pharmaceutical Investments Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Egyptian International Pharmaceutical Investments's interest expense for the three months ended in Mar. 2025 was E£ -326 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was E£-1,124 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Egyptian International Pharmaceutical Investments's Operating Income for the three months ended in Mar. 2025 was E£ 715 Mil. Egyptian International Pharmaceutical Investments's Interest Expense for the three months ended in Mar. 2025 was E£ -326 Mil. Egyptian International Pharmaceutical Investments's Interest Coverage for the quarter that ended in Mar. 2025 was 2.20. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Egyptian International Pharmaceutical Investments Interest Expense Historical Data

The historical data trend for Egyptian International Pharmaceutical Investments's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egyptian International Pharmaceutical Investments Interest Expense Chart

Egyptian International Pharmaceutical Investments Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-109.54

-136.25

-195.42

-388.52

-928.54

Egyptian International Pharmaceutical Investments Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Interest Expense	Get a 7-Day Free Trial															-130.40	-222.75	-281.43	-293.96	-325.83

Egyptian International Pharmaceutical Investments Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was E£-1,124 Mil.

Egyptian International Pharmaceutical Investments (CAI:PHAR) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Egyptian International Pharmaceutical Investments's Interest Expense for the three months ended in Mar. 2025 was E£-326 Mil. Its Operating Income for the three months ended in Mar. 2025 was E£715 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was E£4,627 Mil.

Egyptian International Pharmaceutical Investments's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2025 )	/	Interest Expense (Q: Mar. 2025 )
	=	-1	*	715.476	/	-325.828
	=	2.20

The higher the ratio, the stronger the company's financial strength is.

Warning Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Egyptian International Pharmaceutical Investments interest coverage is 1.79, which is low.

Egyptian International Pharmaceutical Investments Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Egyptian International Pharmaceutical Investments (CAI:PHAR) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1st Industrial Zone B1, P.O. Box 149 10th, 10th of Ramadan, EGY

Website

http://www.eipico.com.eg

Egyptian International Pharmaceutical Investments is an Egypt based company pharmaceutical generic drugs. It holds license agreements with a group of pharmaceutical companies to produce their products locally and replace the imported ones. The company produces dosage forms, Spansule capsules, Antibiotics, Lyophilized Products. It exports its products to African, Asian and East European and Latin American Countries.